Efficacy and clinical relevance of vilazodone in the treatment of major depressive disorder: a pooled analysis of phase III clinical trials

被引：0
|
作者：
Khan, A. [1 ]
Song, W. [2 ]
Edwards, J. [2 ]
Ruth, A. [3 ]
机构：
[1] Northwest Clin Res Ctr, Belleview, FL USA
[2] Forest Res Inst, Jersey City, NJ USA
[3] Prescott Med Commun Grp, Chicago, IL USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2012年 / 22卷
关键词：
D O I：
10.1016/S0924-977X(12)70379-6
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S253 / S254
页数：2
相关论文
共 50 条
  • [41] Clinical Phenotypes Characterization in Pharmacogenetics Testing Trials for Major Depressive Disorder Treatment
    Minelli, A.
    EUROPEAN PSYCHIATRY, 2022, 65 : S39 - S40
  • [42] ADJUNCTIVE ARIPIPRAZOLE IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER: POOLED DATA ON FUNCTIONING FROM THREE CLINICAL TRIALS
    Loze, J. -Y.
    Gismondi, R.
    Baker, R.
    Nashat, M.
    Corey-Lisle, P.
    Rollin, L.
    Tran, Q. -V.
    Forbes, R.
    Berman, R.
    Marcus, R.
    EUROPEAN PSYCHIATRY, 2010, 25
  • [43] CLINICAL RELEVANCE OF FATIGUE AS A RESIDUAL SYMPTOM IN MAJOR DEPRESSIVE DISORDER
    Fava, Maurizio
    Ball, Susan
    Nelson, J. Craig
    Sparks, JonDavid
    Konechnik, Thomas
    Classi, Peter
    Dube, Sanjay
    Thase, Michael E.
    DEPRESSION AND ANXIETY, 2014, 31 (03) : 250 - 257
  • [44] Clinical Efficacy of Laquinimod for the Treatment of Multiple Sclerosis; Pooled Analyses from the ALLEGRO and BRAVO Phase III Trials
    Vollmer, Timothy
    Comi, Giancarlo
    Sorensen, Per Solberg
    Arnold, Douglas
    Filippi, Massimo
    Statinova, Olena
    Kobys, Tetyana
    Becker, Elke
    Jeffery, Douglas
    Montalban, Xavier
    Kappos, Ludwig
    Boyko, Alexey
    Selmaj, Krzysztof
    Zipp, Frauke
    Havrdova, Eva
    Cohen, Jeffrey
    NEUROLOGY, 2012, 78
  • [45] Efficacy of adjunctive brexpiprazole on the core symptoms of major depressive disorder: A post hoc analysis of two pooled clinical studies
    Nelson, J. Craig
    Weiller, Emmanuelle
    Zhang, Peter
    Weiss, Catherine
    Hobart, Mary
    JOURNAL OF AFFECTIVE DISORDERS, 2018, 227 : 103 - 108
  • [46] Levomilnacipran in the treatment of major depressive disorder: Functional health and well-being efficacy results from a phase III clinical trial
    Blum, S. I.
    Tourkodimitris, S.
    Ruth, A.
    Hussainzada, N.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 181 - 182
  • [47] LEVOMILNACIPRAN IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER: FUNCTIONAL HEALTH AND WELL-BEING EFFICACY RESULTS FROM A PHASE III CLINICAL TRIAL
    Blum, S., I
    Tourkodimitris, S.
    Ruth, A.
    VALUE IN HEALTH, 2012, 15 (04) : A91 - A91
  • [48] Clinical Efficacy of rTMS Treatment and Functional Connectivity in Youth with Major Depressive Disorder
    Tapia, Clara
    Chenji, Sneha
    Stone, Kayla
    Swansburg, Rose
    Lyngberg, Kristina
    Carlson, Helen
    Bray, Signe
    Kopala-Sibley, Daniel
    Rittenbach, Katherine
    MacMaster, Frank
    BIOLOGICAL PSYCHIATRY, 2021, 89 (09) : S193 - S193
  • [49] Clinical efficacy of rTMS treatment and functional connectivity in youth with major depressive disorder
    Tapia, Clara
    Chenji, Sneha
    Stone, Kayla
    Swansburg, Rose
    Lyngberg, Kristina Kim
    Carlson, Helen
    Bray, Signe Lauren
    Kopala-Sibley, Daniel
    Rittenbach, Katherine
    MacMaster, Frank P.
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2022, 47 (03): : S13 - S13
  • [50] The role of memantine in the treatment of major depressive disorder: Clinical efficacy and mechanisms of action
    Amidfar, Meysam
    Reus, Gislaine Z.
    Quevedo, Joao
    Kim, Yong-Ku
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2018, 827 : 103 - 111
12345